Name: UMIN ID:
Unique ID issued by UMIN | UMIN000032557 |
---|---|
Receipt number | R000037116 |
Scientific Title | An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance |
Date of disclosure of the study information | 2018/05/30 |
Last modified on | 2021/05/12 10:10:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/05/11 18:35:09 | ||
2 | Update | 2019/02/06 23:28:19 | Recruitment status |
|
3 | Update | 2019/10/30 01:03:06 | Date of IRB Last follow-up date Other related information |
|
4 | Update | 2019/11/05 08:44:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
5 | Update | 2019/11/05 08:47:58 | Other related information |
|
6 | Update | 2019/11/08 09:33:49 | Last name of contact person Last name of contact person |
|
7 | Update | 2019/11/09 08:31:00 | Public title Scientific Title |
|
8 | Update | 2019/11/09 08:32:08 | Other related information |
|
9 | Update | 2020/05/31 10:04:11 | Recruitment status |
|
10 | Update | 2020/11/10 10:00:08 | Last follow-up date |
|
11 | Update | 2020/11/10 10:00:38 | ||
12 | Update | 2021/05/12 10:10:02 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |